力诺药包
(301188)
| 流通市值：69.13亿 | | | 总市值：69.13亿 |
| 流通股本：2.68亿 | | | 总股本：2.68亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 672,929,491.41 | 320,071,196.64 | 981,471,630.66 | 721,014,626.29 |
| 营业总成本 | 636,519,991.38 | 271,686,611.05 | 954,115,373.27 | 684,502,021.07 |
| 其他经营收益 | | | | |
| 营业利润 | 40,242,775.55 | 50,339,518.64 | 50,622,238.5 | 57,919,041.74 |
| 利润总额 | 41,168,297.04 | 50,645,854 | 49,219,741.86 | 57,883,617.06 |
| 净利润 | 31,157,397.12 | 41,002,475.01 | 39,660,429.38 | 50,882,334.53 |
| 每股收益 | | | | |
| 其他综合收益 | -426,511.52 | - | 153.81 | - |
| 综合收益总额 | 30,730,885.6 | 41,002,475.01 | 39,660,583.19 | 50,882,334.53 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 1,365,783,666.17 | 1,381,192,676.34 | 1,397,216,763.86 | 1,284,585,592.42 |
| 非流动资产: | | | | |
| 非流动资产合计 | 1,466,869,698.54 | 1,372,155,252.19 | 1,307,978,796.07 | 1,276,732,667.12 |
| 资产总计 | 2,832,653,364.71 | 2,753,347,928.53 | 2,705,195,559.93 | 2,561,318,259.54 |
| 流动负债: | | | | |
| 流动负债合计 | 577,746,172.74 | 459,612,275.22 | 454,149,841.48 | 462,651,820.72 |
| 非流动负债: | | | | |
| 非流动负债合计 | 300,407,508.32 | 333,371,742.5 | 677,910,121.48 | 494,325,777.96 |
| 负债合计 | 878,153,681.06 | 792,984,017.72 | 1,132,059,962.96 | 956,977,598.68 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 1,954,499,683.65 | 1,960,363,910.81 | 1,573,135,596.97 | 1,604,340,660.86 |
| 股东权益合计 | 1,954,499,683.65 | 1,960,363,910.81 | 1,573,135,596.97 | 1,604,340,660.86 |
| 负债和股东权益合计 | 2,832,653,364.71 | 2,753,347,928.53 | 2,705,195,559.93 | 2,561,318,259.54 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 529,274,110.39 | 239,205,585.3 | 844,984,280.74 | 636,400,328.38 |
| 经营活动现金流出小计 | 597,568,663.63 | 253,096,337.37 | 864,309,798.85 | 696,872,596.62 |
| 经营活动产生的现金流量净额 | -68,294,553.24 | -13,890,752.07 | -19,325,518.11 | -60,472,268.24 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 158,869,125.88 | 50,729,588.35 | 863,258,781.02 | 532,008,654.31 |
| 投资活动现金流出小计 | 295,752,501.12 | 118,859,505.25 | 990,911,606.96 | 610,616,100.13 |
| 投资活动产生的现金流量净额 | -136,883,375.24 | -68,129,916.9 | -127,652,825.94 | -78,607,445.82 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 94,979,519.75 | 6,894,254.45 | 274,891,333.33 | 87,102,350.92 |
| 筹资活动现金流出小计 | 36,269,247.48 | 4,327,657.96 | 125,745,280.94 | 78,343,927.4 |
| 筹资活动产生的现金流量净额 | 58,710,272.27 | 2,566,596.49 | 149,146,052.39 | 8,758,423.52 |
| 汇率变动对现金及现金等价物的影响 | -3,649,122.35 | -1,023,545.25 | -599,088.13 | - |
| 现金及现金等价物净增加额 | -150,116,778.56 | -80,477,617.73 | 1,568,620.21 | -130,321,290.54 |
| 期末现金及现金等价物余额 | 252,198,218.64 | 321,837,379.47 | 402,314,997.2 | 270,425,086.45 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -150,116,778.56 | - | 1,568,620.21 | - |
最新报告期：2026-09-03| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 长江证券 | 李浩,范超 | 0.38 | 0.66 | 0.91 | 2026-09-03 |